Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Patients with Significant Metabolic Syndrome or Type 2 Diabetes: Tirzepatide's glycemic outcomes in diabetic patients HbA1c reductions of 2.02.3% are among the largest documented for any antidiabetic medication
What does this mean for the tirzepatide levocarnitine blend specifically
In combination with l-carnitine, it provides dual support for energizing the heart and muscles, unlike most forms of carnitine
Marketed by: Lilly USA, LLC Indianapolis, IN 46285, USA Copyright 2026, Eli Lilly and Company
Will I need to stay on treatment after I reach my goal
US$ 20.83
US$ 26.02
US$ 24.15
US$ 24.93
US$ 20.27
US$ 23.62
US$ 25.67
